Virtual Medicinal Product (VMP)
-
Nelarabine 250mg/50ml solution for infusion vials
Name Details
Current Name
Nelarabine 250mg/50ml solution for infusion vials
|
Start Date
19-01-2009
|
End Date
|
Previous Name
Nelarabine 250mg/50ml solution for injection vials
|
Start Date
03-10-2007
|
End Date
18-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 50.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01BB07
BNF |
Current BNF
08010300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010300
|
Start Date
08-05-2008
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
12212411000001103 |
03-10-2007 |
|
VMP Ingredients
VMP ingredients table
Nelarabine |
Based on Ingredient Substance |
|
5 mg |
1 ml |
Name
Nelarabine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Nelarabine
-
VMP
(Current) Nelarabine 250mg/50ml solution for i...
Virtual Medicinal Product Pack (VMPP) Information